Toronto Dominion Bank
INDV icon

Toronto Dominion Bank’s Indivior Pharmaceuticals INDV Stock Holding History

Toronto Dominion Bank’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,484
Closed -$624K – 2390
2026
Q1 		$624K Buy
+20,484
New +$676K ﹤0.01% 1395
2024
Q3 		– Sell
-1,141,377
Closed -$18.4M – 1297
2024
Q2 		$18.4M Sell
1,141,377
-953,488
-46% -$17.2M 0.03% 333
2024
Q1 		$44.9M Buy
2,094,865
+769,000
+58% +$14.4M 0.07% 183
2023
Q4 		$20.2M Hold
1,325,865
– – 0.03% 370
2023
Q3 		$30.6M Hold
1,325,865
– – 0.05% 264
2023
Q2 		$30.7M Buy
+1,325,865
New +$30.4M 0.05% 275

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Toronto Dominion Bank's INDV Position: Q2 2026 in Review

Toronto Dominion Bank sold out of Indivior Pharmaceuticals (INDV) in Q2 2026, closing a stake of 20,484 shares — an estimated $624K sold.

Toronto Dominion Bank first reported a position in INDV in Q2 2023 and held it in 6 quarters. The position peaked at $44.9M in Q1 2024. 339 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Toronto Dominion Bank reported no remaining Indivior Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Toronto Dominion Bank sold 20,484 Indivior Pharmaceuticals shares in Q2 2026, an estimated $624K.
  • Toronto Dominion Bank first reported a position in Indivior Pharmaceuticals in Q2 2023 and held it in 6 quarters.
  • Toronto Dominion Bank's Indivior Pharmaceuticals position peaked at $44.9M in Q1 2024.
  • 339 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.